[Federal Register Volume 62, Number 30 (Thursday, February 13, 1997)]
[Notices]
[Page 6788]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-3660]



[[Page 6788]]

-----------------------------------------------------------------------


DEPARTMENT OF HEALTH AND HUMAN SERVICES

Studies of Adverse Effects of Marketed Drugs, Biologics, and 
Devices; Availability of Grants (Cooperative Agreements); Request for 
Applications; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of February 5, 1997 (62 FR 5429). 
The document announced the availability of $1.4 million in Fiscal Year 
1997 funds for cooperative agreements to study adverse effects of 
marketed drugs, biologics, and devices. The document was published with 
an incorrect application acceptance date. This document corrects that 
error.

FOR FURTHER INFORMATION CONTACT: Robert L. Robins, Grants Management 
Officer, Division of Contracts and Procurement Management (HFA-520), 
Food and Drug Administration, Park Bldg., rm. 3-40, 5600 Fishers Lane, 
Rockville, MD 20857, 301-443-6170.

    In FR Doc. 97-2870, appearing on page 5429, in the Federal Register 
of Wednesday, February 5, 1997, the following correction is made:
    1. On page 5432, in the first column, in the first full paragraph, 
in line four, ``March 14, 1997'' is corrected to read ``March 21, 
1997''.

    Dated: February 7, 1997.
William K. Hubbard,
Associate Commissioner for Policy Coordination.
[FR Doc. 97-3660 Filed 2-12-97; 8:45 am]
BILLING CODE 4160-01-F